Zhenzhun Biotech is a biotech company founded in 2016 with a focus on the research, development, production, and sales of in vitro diagnostic equipment consumables. The company's mission revolves around advancing life and health through its innovative approach. Zhenzhun Biotech's core team comprises top-tier enterprise management professionals from leading global medical device companies, along with scientists and technical experts in micro-nano processing, precision instruments, image algorithms, and biological reagents. Notably, the company has successfully pioneered China's first chip-type digital PCR instrument with its own intellectual property rights.
Zhenzhun Biotech operates primarily in the Biotechnology and Health Care industries, and its growth trajectory has gained momentum with a recent CNY100.00M Series A investment at 09 March 2022, led by Grand Mount Capital. This substantial investment reflects confidence in the company's potential and signifies an exciting phase of expansion and innovation. As the company continues to expand, it is actively seeking talented individuals to join its team and contribute to its significant endeavors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | CNY100.00M | 1 |
|
09 Mar 2022 |
| Series A | Unknown | 1 |
|
01 Aug 2019 |
No recent news or press coverage available for Zhenzhun Biotech.
We care about your data, and we'd love to use cookies make your experience better.
